NEVVI Medicare utilization intelligence

← back

Provider profile

MEHRVARZ SARSHEKEH, AMIR M.D

Internal Medicine · NPI 1649697707 · EVERETT, WA

4
Groups
37
Codes · 2024
32,988
Disclosed services

MEHRVARZ SARSHEKEH, AMIR is a Internal Medicine in EVERETT, WA, a member of 4 medical groups, who billed 37 distinct codes to Medicare Part B in 2024.

Groups: INFINITY CANCER CARE PC (BELLINGHAM, WA) · JEFFERSON COUNTY PUBLIC HOSPITAL DISTRICT NO 2 (PORT TOWNSEND, WA) · OPTUM CARE WASHINGTON PLLC (EVERETT, WA) · PROVIDENCE HEALTH AND SERVICES- WASHINGTON (EVERETT, WA) — member of 4 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

32,988
disclosed services
37
codes billed to Medicare Part B
Prior year · CY2023 26,998 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml premiumpremium premiumpremium
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj premiumpremium premiumpremium
J9267 Injection, paclitaxel, 1 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
80053 Blood test, comprehensive group of blood chemicals premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J9045 Injection, carboplatin, 50 mg premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
J3489 Injection, zoledronic acid, 1 mg premiumpremium premiumpremium
82728 Ferritin (blood protein) level premiumpremium premiumpremium
83540 Iron level premiumpremium premiumpremium
84466 Transferrin (iron binding protein) level premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
83735 Magnesium level premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
84443 Blood test, thyroid stimulating hormone (tsh) premiumpremium premiumpremium
96523 Irrigation of implanted venous access drug delivery device premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes premiumpremium premiumpremium
82784 Gammaglobulin (immune system protein) measurement premiumpremium premiumpremium
83615 Lactate dehydrogenase (enzyme) level premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
82607 Cyanocobalamin (vitamin b-12) level premiumpremium premiumpremium
86706 Hepatitis b surface antibody measurement premiumpremium premiumpremium
87340 Detection test by immunoassay technique for hepatitis b surface antigen premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.